Bank Of New York Mellon Corp Heron Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$528 Trillion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.51 - $3.25 $506,195 - $1.09 Million	335,229 New	335,229 $506 Million
Q4 2022 Feb 14, 2023	BUY	$2.25 - $4.67 $786,183 - $1.63 Million	349,415 New	349,415 $873,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $96,518 - $194,850	36,285 Added 11.65%	347,636 $1.47 Million
Q2 2022 Aug 15, 2022	BUY	$2.3 - $6.29 $15,221 - $41,627	6,618 Added 2.17%	311,351 $869,000
Q1 2022 May 11, 2022	BUY	$4.63 - $9.94 $27,233 - $58,467	5,882 Added 1.97%	304,733 $1.74 Million
Q4 2021 Feb 11, 2022	SELL	$8.35 - $12.6 $275,433 - $415,623	-32,986 Reduced 9.94%	298,851 $2.73 Million
Q3 2021 Nov 12, 2021	BUY	$10.13 - $15.0 $326,702 - $483,765	32,251 Added 10.77%	331,837 $3.55 Million
Q2 2021 Aug 11, 2021	SELL	$13.27 - $18.48 $542,583 - $755,610	-40,888 Reduced 12.01%	299,586 $4.65 Million
Q1 2021 May 13, 2021	SELL	$14.49 - $20.72 $215,770 - $308,541	-14,891 Reduced 4.19%	340,474 $5.52 Million
Q4 2020 Feb 09, 2021	SELL	$14.61 - $22.14 $40,162 - $60,862	-2,749 Reduced 0.77%	355,365 $7.52 Million
Q3 2020 Nov 12, 2020	SELL	$13.67 - $17.77 $150,985 - $196,269	-11,045 Reduced 2.99%	358,114 $5.31 Million
Q2 2020 Aug 12, 2020	BUY	$10.89 - $21.47 $148,147 - $292,077	13,604 Added 3.83%	369,159 $5.43 Million
Q1 2020 May 06, 2020	SELL	$10.23 - $24.56 $79,783 - $191,543	-7,799 Reduced 2.15%	355,555 $4.17 Million
Q4 2019 Feb 14, 2020	BUY	$17.42 - $26.61 $504,866 - $771,211	28,982 Added 8.67%	363,354 $8.54 Million
Q3 2019 Nov 07, 2019	BUY	$16.36 - $21.39 $402,488 - $526,236	24,602 Added 7.94%	334,372 $6.19 Million
Q2 2019 Aug 12, 2019	BUY	$16.93 - $26.22 $203,667 - $315,426	12,030 Added 4.04%	309,770 $5.76 Million
Q1 2019 May 14, 2019	SELL	$23.15 - $28.34 $7,523 - $9,210	-325 Reduced 0.11%	297,740 $7.28 Million
Q4 2018 Feb 11, 2019	SELL	$22.03 - $32.01 $335,891 - $488,056	-15,247 Reduced 4.87%	298,065 $7.73 Million
Q3 2018 Nov 09, 2018	BUY	$30.0 - $40.85 $417,840 - $568,958	13,928 Added 4.65%	313,312 $0
Q2 2018 Aug 06, 2018	BUY	$26.4 - $42.0 $527,102 - $838,572	19,966 Added 7.15%	299,384 $11.6 Million
Q1 2018 May 15, 2018	BUY	$18.43 - $28.8 $1.45 Million - $2.27 Million	78,719 Added 39.22%	279,418 $7.71 Million
Q4 2017 Feb 09, 2018	BUY	$14.8 - $18.85 $2.97 Million - $3.78 Million	200,699	200,699 $3.63 Million

Others Institutions Holding HRTX

# of Institutions

193

Shares Held

129M

Call Options Held

94.7K

Put Options Held

148K

Rubric Capital Management LP New York, NY

26.7M
Shares

$51 Million
2.77% of portfolio
Vanguard Group Inc Valley Forge, PA

8.62M
Shares

$16.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$15.9 Million
0.0% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

7.6M
Shares

$14.5 Million
0.05% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$13.3 Million
58.47% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $227M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account